TAKOMA PARK, Md.--(BUSINESS WIRE)--US Medical Innovations, LLC (USMI), a biomedical device specification manufacturer and subsidiary of US Patent Innovations, LLC (USPI), announces that the People’s Republic of China (PRC) Patent Office has issued a Notification of Granting a Patent Right as well as a Notification of Completion of Formalities for Patent Register for the Canady Hybrid Plasma™ (CHP) technology. This follows a similar patent recognition by Japan. CHP simultaneously cuts and coagulates biological tissue. The Canady Hybrid Plasma™ Scalpel, a revolutionary device now beginning to secure a strong initial foothold in the U.S. surgical market, uses this technology. The PRC Patent Office’s recent approval represents another important advancement towards the company’s international distribution plans.
The US FDA-registered Canady Hybrid Plasma™ Scalpel (CHPS) is a smart multi-functional electrosurgical handpiece, delivering a precise beam less than 1.0mm in diameter and a depth of injury as low as 0.1mm. The CHP technology decreases tissue damage, perioperative blood loss, operative time, blood transfusion rates, and helps surgeons perform total knee replacements without the use of a tourniquet. For more information, click here. The CHPS incorporates four separate operating modes: hybrid plasma, argon plasma coagulation, conventional monopolar cut and coagulation, which can be used in a range of subspecialties, such as cardiovascular surgery, endoscopy, ENT, general surgery, gynecology, neurosurgery, orthopedics, plastics, surgical oncology, thoracic surgery and dermatology.
Jerome Canady, M.D., CEO, commented, “Patent recognition in China follows recognition in Japan, providing intellectual property approval and protection for our products to pave the way for sales program in the Chinese market, the next step in our plans for global expansion.”
About US Medical Innovations
US Medical Innovations, LLC (USMI) is a U.S. based, FDA-registered biomedical device specification manufacturing company founded by surgeon and inventor, Jerome Canady, M.D. USMI’s focus is developing advanced, innovative and affordable plasma electrosurgical devices. The company’s products are designed for ambulatory and inpatient endoscopy centers as well as complex surgical procedures.
About US Patent Innovations
US Patent Innovations, LLC (USPI), parent company of USMI, is a private investor-owned US company founded by Jerome Canady, M.D. USPI has over 120 partners, whose main focus is to invest in new and innovative technologies in the fields of electrosurgery, plasma medicine and surgical devices.
